
Bayer Stock
Multinational pharmaceutical and life sciences company
Sign up today and learn more about Bayer Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Bayer Stock
Bayer operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. Friedrich Bayer and Johann Friedrich Weskott founded Bayer on August 1, 1863. It has its headquarters in Leverkusen in Germany.
Funding History
April 2018 | $3.0B |
---|
Management
Global Head of Digital Health and Innovation
Eugene Borukhovich
Head at Bayer Venture Investments
Juergen Eckhardt
Global Head of Digital Transformation
Saskia Steinacker
Head of Leaps
Axel Bouchon
Head of Brand Management
Jun Tang
Crop Science Division, representing SETAC DRAW
Andrew Chapple
Head of IT Business Partnering Research
Angeli Möller
General Counsel
Xi Zhang
Global Corporate Web and Social Strategy Lead
Kate Humphrey
Director of Pharmaceuticals Clinical Project Management
Tarja Jalava
Press
BuzzFeed - Apr, 8 2020
Wanna Know What Your Job Was In A Past Life? Choose Some Food To Find OutWall Streets Journal - Apr, 3 2020
Coronavirus Bogs Down Bayer’s Roundup Settlement TalksWall Streets Journal - Mar, 13 2020
Bayer Advances Toward Resolving Roundup LitigationNew York Times - Mar, 12 2020
How Big Pharma Grew Addicted to Big ProfitsWall Streets Journal - Feb, 26 2020
Bayer Chairman Steps Down in Midst of Roundup Legal BattleWall Streets Journal - Jan, 27 2020
Bayer Looks to Emerging Technique to Overcome AI Data ChallengesWall Streets Journal - Jan, 18 2020
‘Herbert Bayer: Bauhaus Master’ Review: Graphic Design, Poetic and StrikingForbes - Nov, 7 2019
Advanced Breeding: Making The Most Of Every ResourceForbes - Nov, 7 2019
Biodiversity And Soil Health: How Caring For One Protects The OtherEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase